Vitrolife
Vitrolife AB, headquartered in Sweden, is a leading player in the reproductive health industry, specialising in products and services for assisted reproductive technology (ART). Founded in 1994, the company has established a strong presence in key operational regions, including Europe, North America, and Asia.
Vitrolife is renowned for its innovative solutions, including culture media, cryopreservation products, and laboratory equipment designed to enhance the success rates of IVF treatments. Their commitment to quality and research has positioned them as a trusted partner for fertility clinics worldwide. With a focus on advancing reproductive medicine, Vitrolife continues to achieve significant milestones, solidifying its reputation as a pioneer in the field.
+27 vs industry average
Vitrolife’s score of 65 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Vitrolife?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Vitrolife's reported carbon emissions
In 2025, Vitrolife reported total carbon emissions of approximately 20.7 million kg CO2e, comprising 610,000 kg CO2e from Scope 1, 1,260,000 kg CO2e from Scope 2, and 18,849,000 kg CO2e from Scope 3 emissions. This represents a slight decrease from 2023, where total emissions were about 21.6 million kg CO2e. The company has set ambitious near-term targets, committing to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030 from a 2023 base year. Additionally, Vitrolife aims to cut Scope 3 emissions from various categories, including purchased goods and services, by 51.6% per million SEK value added within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and reflect Vitrolife's commitment to addressing climate change and reducing its carbon footprint. The company is headquartered in Sweden and operates within the healthcare equipment and supplies sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Vitrolife’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Vitrolife yet.
Scope 3 top emissions categories
9 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Vitrolife
Frequently asked questions
Common questions about Vitrolife’s sustainability data and climate commitments
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project